DEREK KLEIER: Open Payments
NPI 1568955466 · GRAND ISLAND, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 39 payments from 9 companies in 2025. Trend: 2023 $398 · 2024 $414 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $194 |
| Abbott Laboratories | 3 | $72 |
| Novo Nordisk Inc | 4 | $66 |
| Seqirus USA Inc | 1 | $26 |
| Optinose US, Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 5 | $21 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $19 |
Products named: VRAYLAR, FREESTYLE LIBRE 3, Rybelsus, QULIPTA, UBRELVY, Flucelvax, Xhance, SPRAVATO.
Industry payments across NE — which companies pay providers there.
